Login / Signup
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B.
Cheng-Yuan Peng
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
hepatitis b virus
dendritic cells
cell therapy
recombinant human